A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer
Sarah E. Paraghamian(University of North Carolina at Chapel Hill), Victoria Bae‐Jump(University of North Carolina at Chapel Hill), Joshua E. Allen(Chimerix (United States)), Jianqing Qiu(West China Medical Center of Sichuan University), Varun V. Prabhu(Roswell Park Comprehensive Cancer Center), Tianran Hao(University of North Carolina at Chapel Hill), Chunxiao Zhou(University of North Carolina at Chapel Hill), Ziyi Zhao(Chengdu University of Traditional Chinese Medicine), Yali Fan(Capital Medical University), Wenchuan Sun(University of North Carolina at Chapel Hill), Hongyan Suo(University of North Carolina at Chapel Hill), Gabrielle M. Hawkins(University of North Carolina at Chapel Hill), Xin Zhang(Hefei University)
Cited by 11
Related Papers
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNFα
|Cell stem cell|2012|365
Distinct responses of soil bacterial and fungal communities to changes in fertilization regime and crop rotation
|Geoderma|2018|348
Medial preoptic area in mice is capable of mediating sexually dimorphic behaviors regardless of gender
|Nature Communications|2018|256
Primary Sources and Secondary Formation of Organic Aerosols in Beijing, China
|Environmental Science & Technology|2012|238